Walnut Creek, CA - Feb 22
... and Drug Safety arenas for large and midsize biotech and pharma clients. ASG had roughly $60million in revenue in 2011 and will grow to roughly $75 million in 2012. The company plans to increase to $300/+ million in revenue in the next 5 years through a strategy of sustained organic and acquisitive growth. ASG is led by a founding CEO and backed by a Private Equity group Sycamore Hill Capital. ASG has its corporate headquarters in Walnut Creek as well as large offices in Denver and Charlotte and satellite ...
Save Job View on the Map